Register for an Online Account
Contact Us
Login
Home
Welcome, Guest
Product Partnering
Technology Partnering
How To Use
About Us
Product Partnering
Search Products
Submit Products
The Latest Updated Products
Technology Partnering
Search Technologies
Submit Technologies
The Latest Updated Technologies
How To Use
How To Use
Sample Data View
FAQ
About Us
About PP
Why PP
Contact us
The Latest Updated Products
Home > Product Partnering >
The Latest Updated Products
Basic Search
Search
Displaying
1 of 4
10
20
50
results per page
Prev
Next
The Latest Updated Products 게시물 리스트
product_code
originator
Lab Code or BRAND NAME
API
Action mechanism
Indication
Latest development stage
Details
PP100504002206
CG Invites Co., Ltd., CrystalGenomics Inc.
CG200745 Inj.
ivaltinostat
A histone ..
Pancreatic..
Phase III, Phase II completed, Phase II, Phase II, Dropped
View Details
PP100504002208
CG Invites Co., Ltd., CrystalGenomics Inc.
CG-549
nilofabicin
Specific i..
Methicilli..
Phase II completed
View Details
PP190709017304
Nxera Pharma Corp. (since Apr 2024), Sosei Heptares, a Sosei
HTL0016878, NBI-1117568
A muscarin..
Schizophre..
Phase II
View Details
PP190709017306
Nxera Pharma Corp. (since Apr 2024), Sosei Heptares, a Sosei
KY1051
A CXCR4 mA..
Cancer
Preclinical
View Details
PP190709017307
Nxera Pharma Corp. (since Apr 2024), Sosei Heptares, a Sosei
HTL0014242, TMP-301
A potent a..
Alcohol an..
Phase I
View Details
PP200324018016
CG Invites Co., Ltd., CrystalGenomics Inc.
CG-650
polmacoxib and tramadol HCl
A dual inh..
Osteoarthr..
Phase I completed
View Details
PP210421018594
CG Invites Co., Ltd., CrystalGenomics Inc.
CG-745 Oral
ivaltinostat
A histone ..
Non-alcoho..
Phase I, Phase I
View Details
PP210825018876
Nxera Pharma Corp. (since Apr 2024), Sosei Heptares Therapeutics Ltd., a Sosei Group
PF-07054894
A potent C..
Ulcerative..
Phase I, Phase I
View Details
PP210825018877
Nxera Pharma Corp. (since Apr 2024), Sosei Heptares Therapeutics Ltd., a Sosei Group
PF-07258669
A melanoco..
Geriatric ..
Phase I
View Details
PP220304019469
Neurobiogen
KDS2010
A selectiv..
Obesity, A..
Phase II, Phase II
View Details